HOME >> BIOLOGY >> NEWS
Small trial shows daclizumab add-on therapy improves MS outcome

A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements. The trial was led by investigators at the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health. Findings will appear in the Early Edition of the Proceedings of the National Academy of Sciences1 the week of May 24-28, 2004.

MS is a chronic disease marked by inflammation in the central nervous system and development of lesions in the brain. Messages from the brain to the body are interrupted as nerve fibers begin to lose their protective coating of myelin, resulting in muscle weakness, problems with vision and coordination, pain, and, in some patients, cognitive impairments. Approximately 250,000 to 350,000 people in the United States suffer from MS and about 200 new cases are diagnosed by physicians each week. There is no cure for the disorder.

NINDS investigator Roland Martin, M.D., and colleagues studied 11 patients with either relapsing-remitting 2 or secondary progressive 3 MS. Each patient was treated with beta interferon - a naturally occurring antiviral protein commonly used to treat MS. Patients also received 7 treatments of daclizumab (a genetically engineered human antibody that blocks the interleukin-2 receptor on immune cells) administered intravenously at 2-week, and later, 4-week intervals.

Ten patients showed a reduction in both the severity and number of brain lesions as demonstrated by magnetic resonance imaging. The decrease in new lesions, as well as the total decrease in lesions, occurred gradually over a 2-month span. Improvement was also seen on a neurological
'"/>

Contact: Paul Girolami
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
24-May-2004


Page: 1 2

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small RNA surmounts large cancer problem
4. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2019)... ... , ... R3 Stem Cell is now offering its comprehensive Online Stem ... to use during checkout is FIFTYOFF and applies to both the one month access ... therapies with over 12,000 successful stem cell procedures performed nationwide. A couple years ago, ...
(Date:11/5/2019)... ... 2019 , ... Catalent, the leading global provider of advanced ... health products, today announced it will present at the upcoming World Orphan Drug ... 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, Ph.D., ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards releases ... Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate CA, ... Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal delta” ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... Diversified Technologies, Inc. has ... and vegetables per hour to improve processing. , The DTI Industrial PEF Unit can ... hour to increase juice yields by up to 50% and achieve up to an ...
(Date:11/5/2019)... ... November 05, 2019 , ... Ole, a German Shepherd, was demonstrating signs of osteoarthritis ... jumping. Though his energy level and his willingness to play were normal, it was ... Holly Mullen of VCA Emergency Animal Hospital and Referral Center in San Diego, ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer ... South Dakota School of Mines & Technology are exploring new ways to regulate ... , If successful, the technique would prove to be a drug-free, minimally invasive ...
(Date:10/29/2019)... ... 2019 , ... Researchers at Sony recently demonstrated biometric identification ... , researchers identified people by the image of a small patch on their ... fingerprints and vasculature. , The new CMS4 series of cameras offer 4 ...
Breaking Biology Technology:
Cached News: